Almac Discovery United Kingdom

Almac Discovery is a biopharmaceutical company focussed on the discovery and development of novel therapeutics for oncology indications. e.g. ALM201 is a potent yet non-toxic targetted tubulin binding peptide inhibitor of angiogenesis.

Company type
Robert Grundy
LinkedIn logo

Autifony Therapeutics

Barbara Domayne-Hayman


PolyTherics is a biotechnology company that applies precision chemistry to develop protein and peptide-based drugs. PolyTherics is a biotechnology company that offers a comprehensive range of site-specific conjugation technologies and polymer-based technologies which are being applied to the development and enhancement of biologicals and other therapeutic entities.

Donna Hackett